|
|
|
Volumn 17, Issue 4, 2011, Pages
|
|
Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL;
CALCIPOTRIOL;
CALCITRIOL;
CORTICOSTEROID;
CYCLOSPORIN;
EFALIZUMAB;
ETANERCEPT;
ETRETIN;
INFLIXIMAB;
METHOTREXATE;
PIMECROLIMUS;
TACROLIMUS;
USTEKINUMAB;
DERMATOLOGICAL AGENT;
DRUG DERIVATIVE;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
AGED;
BIOLOGICAL THERAPY;
CASE REPORT;
DISEASE ACTIVITY;
DISEASE DURATION;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
FEMALE;
HUMAN;
MEDICAL HISTORY;
NOTE;
OUTCOME ASSESSMENT;
PSORIASIS;
PSORIASIS SEVERITY INDEX;
REFRATORY PSORIASIS;
SYSTEMIC THERAPY;
TOPICAL TREATMENT;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
DRUG COMBINATION;
LETTER;
TREATMENT OUTCOME;
ACITRETIN;
ADRENAL CORTEX HORMONES;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CALCITRIOL;
CYCLOSPORINE;
DERMATOLOGIC AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
METHOTREXATE;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TACROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 79960731385
PISSN: 10872108
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (4)
|
